Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy
Biotech
Enlivex defends sepsis data that sank stock
Enlivex Therapeutics had a message Friday for investors who halved its share price: You’re misreading our data.
Nick Paul Taylor
Apr 12, 2024 9:30am
Ginkgo loads up Modulus CAR assets, latest in a string of deals
Apr 2, 2024 7:01am
BioCardia rejigs phase 3 heart failure data to find a path
Mar 4, 2024 10:15am
Kyverna overshoots raised IPO expectations with $319M offering
Feb 8, 2024 8:24am
Neurona knocks out $120M raise a year after layoffs
Feb 8, 2024 8:00am
Regeneron to fill gaps in obesity, break ground in cell therapy
Feb 2, 2024 10:25am